Home
COLL
COLL News

Latest Collegium Pharmaceutical Inc. (COLL) News on July 1, 2025

Argus Research

7 days ago

COLL: Raising target price to $32.00

1 Russell 2000 Stock on Our Watchlist and 2 to Keep Off Your Radar

StockStory

14 days ago

1 Russell 2000 Stock on Our Watchlist and 2 to Keep Off Your Radar

Argus Research

21 days ago

COLL: Rating decreased to a HOLD

COLL Q1 Earnings Call: ADHD Portfolio Drives Growth, Management Details Capital Deployment Priorities

StockStory

21 days ago

COLL Q1 Earnings Call: ADHD Portfolio Drives Growth, Management Details Capital Deployment Priorities

3 of Wall Street’s Favorite Stocks with Mounting Challenges

StockStory

21 days ago

3 of Wall Street’s Favorite Stocks with Mounting Challenges

Branded Pharmaceuticals Stocks Q1 In Review: Collegium Pharmaceutical (NASDAQ:COLL) Vs Peers

StockStory

25 days ago

Branded Pharmaceuticals Stocks Q1 In Review: Collegium Pharmaceutical (NASDAQ:COLL) Vs Peers

1 Stock Under $50 with Exciting Potential and 2 to Turn Down

StockStory

a month ago

1 Stock Under $50 with Exciting Potential and 2 to Turn Down

Branded Pharmaceuticals Stocks Q1 Results: Benchmarking Corcept (NASDAQ:CORT)

StockStory

a month ago

Branded Pharmaceuticals Stocks Q1 Results: Benchmarking Corcept (NASDAQ:CORT)

Argus Research

a month ago

COLL: What does Argus have to say about COLL?

Collegium Pharmaceutical's (NASDAQ:COLL) Conservative Accounting Might Explain Soft Earnings

Simply Wall St.

a month ago

Collegium Pharmaceutical's (NASDAQ:COLL) Conservative Accounting Might Explain Soft Earnings

Collegium to Participate in Upcoming Investor Conferences

GlobeNewswire

a month ago

Collegium to Participate in Upcoming Investor Conferences

3 Small-Cap Stocks Facing Headwinds

StockStory

2 months ago

3 Small-Cap Stocks Facing Headwinds

Argus Research

2 months ago

COLL: Rating increased to a BUY

MT Newswires

2 months ago

Collegium Pharmaceutical Signs $25 Million Accelerated Share Buyback Deal With Jefferies

Collegium Announces $25 Million Accelerated Share Repurchase Program

GlobeNewswire

2 months ago

Collegium Announces $25 Million Accelerated Share Repurchase Program

GuruFocus.com

2 months ago

Collegium Pharmaceutical Inc (COLL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ...

Collegium Pharmaceutical (NASDAQ:COLL) Exceeds Q1 Expectations

StockStory

2 months ago

Collegium Pharmaceutical (NASDAQ:COLL) Exceeds Q1 Expectations

Compared to Estimates, Collegium Pharmaceutical (COLL) Q1 Earnings: A Look at Key Metrics

Zacks

2 months ago

Compared to Estimates, Collegium Pharmaceutical (COLL) Q1 Earnings: A Look at Key Metrics

Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Surpass Estimates

Zacks

2 months ago

Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Surpass Estimates

Associated Press Finance

2 months ago

Collegium Pharmaceutical: Q1 Earnings Snapshot

Collegium Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress

GlobeNewswire

2 months ago

Collegium Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress

Collegium Pharmaceutical Inc (COLL) Q1 2025: Everything You Need To Know Ahead Of Earnings

GuruFocus.com

2 months ago

Collegium Pharmaceutical Inc (COLL) Q1 2025: Everything You Need To Know Ahead Of Earnings

Collegium Pharmaceutical (COLL) Q1 Earnings: What To Expect

StockStory

2 months ago

Collegium Pharmaceutical (COLL) Q1 Earnings: What To Expect

Argus Research

2 months ago

COLL: Lowering target price to $28.00

Collegium Pharmaceutical (COLL) Expected to Beat Earnings Estimates: Should You Buy?

Zacks

2 months ago

Collegium Pharmaceutical (COLL) Expected to Beat Earnings Estimates: Should You Buy?

3 Healthcare Stocks That Concern Us

StockStory

2 months ago

3 Healthcare Stocks That Concern Us

Collegium to Report First Quarter 2025 Financial Results on May 8, 2025

GlobeNewswire

2 months ago

Collegium to Report First Quarter 2025 Financial Results on May 8, 2025

Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now?

Zacks

2 months ago

Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now?

Argus Research

2 months ago

COLL: What does Argus have to say about COLL?

Argus Research

3 months ago

COLL: Raising target price to $28.00

2 Reasons to Watch COLL and 1 to Stay Cautious

StockStory

3 months ago

2 Reasons to Watch COLL and 1 to Stay Cautious

Argus Research

3 months ago

COLL: Lowering target price to $27.00

Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) 30% ROE Better Than Average?

Simply Wall St.

3 months ago

Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) 30% ROE Better Than Average?

A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack

StockStory

3 months ago

A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack

Argus Research

3 months ago

COLL: Lowering target price to $31.00

Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference

GlobeNewswire

3 months ago

Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference

Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine’s Annual Meeting

GlobeNewswire

3 months ago

Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine’s Annual Meeting

Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board

GlobeNewswire

3 months ago

Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board

Argus Research

3 months ago

COLL: Raising target price to $32.00

Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks

StockStory

3 months ago

Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks

Teva Pharmaceutical Stock Scores RS Rating Upgrade

Investor's Business Daily

3 months ago

Teva Pharmaceutical Stock Scores RS Rating Upgrade

Collegium Announces Updates to its Board of Directors and Executive Leadership Team

GlobeNewswire

3 months ago

Collegium Announces Updates to its Board of Directors and Executive Leadership Team

MT Newswires

4 months ago

Collegium Pharmaceutical Insider Sold Shares Worth $313,413, According to a Recent SEC Filing

Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health Care

GlobeNewswire

4 months ago

Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health Care

Collegium Pharmaceutical's (NASDAQ:COLL) Solid Earnings Are Supported By Other Strong Factors

Simply Wall St.

4 months ago

Collegium Pharmaceutical's (NASDAQ:COLL) Solid Earnings Are Supported By Other Strong Factors

Argus Research

4 months ago

COLL: Lowering target price to $29.00

Collegium to Participate in Upcoming Investor Conferences

GlobeNewswire

4 months ago

Collegium to Participate in Upcoming Investor Conferences

Collegium Pharmaceutical Full Year 2024 Earnings: In Line With Expectations

Simply Wall St.

4 months ago

Collegium Pharmaceutical Full Year 2024 Earnings: In Line With Expectations

Should You Be Adding Collegium Pharmaceutical (NASDAQ:COLL) To Your Watchlist Today?

Simply Wall St.

4 months ago

Should You Be Adding Collegium Pharmaceutical (NASDAQ:COLL) To Your Watchlist Today?

Is Collegium Pharmaceutical, Inc. (COLL) the Best Small Cap Pharma Stocks to Buy Now?

Insider Monkey

4 months ago

Is Collegium Pharmaceutical, Inc. (COLL) the Best Small Cap Pharma Stocks to Buy Now?

Thomson Reuters StreetEvents

4 months ago

Q4 2024 Collegium Pharmaceutical Inc Earnings Call

GuruFocus.com

4 months ago

Collegium Pharmaceutical Inc (COLL) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ...

Collegium Pharmaceutical (COLL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

4 months ago

Collegium Pharmaceutical (COLL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Beat Estimates

Zacks

4 months ago

Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Beat Estimates

Associated Press Finance

4 months ago

Collegium Pharmaceutical: Q4 Earnings Snapshot

Collegium Pharmaceutical’s (NASDAQ:COLL) Q4 Sales Top Estimates, Stock Jumps 14.1%

StockStory

4 months ago

Collegium Pharmaceutical’s (NASDAQ:COLL) Q4 Sales Top Estimates, Stock Jumps 14.1%

Collegium Reports Record Fourth Quarter and Full-Year 2024 Financial Results

GlobeNewswire

4 months ago

Collegium Reports Record Fourth Quarter and Full-Year 2024 Financial Results

Seeking Clues to Collegium Pharmaceutical (COLL) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics

Zacks

4 months ago

Seeking Clues to Collegium Pharmaceutical (COLL) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics

Collegium Pharmaceutical (COLL) Reports Earnings Tomorrow: What To Expect

StockStory

4 months ago

Collegium Pharmaceutical (COLL) Reports Earnings Tomorrow: What To Expect

GuruFocus.com

4 months ago

What To Expect From Collegium Pharmaceutical Inc (COLL) Q4 2024 Earnings

Argus Research

4 months ago

COLL: Lowering target price to $30.00

Argus Research

4 months ago

COLL: Lowering target price to $31.00

Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025

GlobeNewswire

5 months ago

Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025

Collegium Appoints Nancy S. Lurker to its Board of Directors

GlobeNewswire

5 months ago

Collegium Appoints Nancy S. Lurker to its Board of Directors

Argus Research

5 months ago

COLL: Lowering target price to $32.00

Argus Research

5 months ago

COLL: Lowering target price to $34.00

Argus Research

5 months ago

COLL: What does Argus have to say about COLL?

MT Newswires

6 months ago

Collegium Pharmaceutical Insider Sold Shares Worth $908,628, According to a Recent SEC Filing

MT Newswires

6 months ago

Needham Upgrades Collegium Pharmaceutical to Buy From Hold, Price Target is $46

Collegium Pharmaceutical Unveils 2025 Financial Projections

TipRanks

6 months ago

Collegium Pharmaceutical Unveils 2025 Financial Projections

MT Newswires

6 months ago

Collegium Pharmaceutical Shares Rise After 2025 Guidance

Collegium Provides 2025 Financial Guidance and Business Update

GlobeNewswire

6 months ago

Collegium Provides 2025 Financial Guidance and Business Update

Pulling back 6.0% this week, Collegium Pharmaceutical's NASDAQ:COLL) three-year decline in earnings may be coming into investors focus

Simply Wall St.

6 months ago

Pulling back 6.0% this week, Collegium Pharmaceutical's NASDAQ:COLL) three-year decline in earnings may be coming into investors focus

Argus Research

6 months ago

COLL: Lowering target price to $31.00

Argus Research

6 months ago

COLL: What does Argus have to say about COLL?

Argus Research

7 months ago

COLL: What does Argus have to say about COLL?

Argus Research

7 months ago

COLL: Lowering target price to $32.00

Argus Research

7 months ago

COLL: Raising target price to $33.00

Collegium Pharmaceutical's (NASDAQ:COLL) Performance Is Even Better Than Its Earnings Suggest

Simply Wall St.

8 months ago

Collegium Pharmaceutical's (NASDAQ:COLL) Performance Is Even Better Than Its Earnings Suggest

Is Collegium Pharmaceutical (COLL) a Great Value Stock Right Now?

Zacks

8 months ago

Is Collegium Pharmaceutical (COLL) a Great Value Stock Right Now?

Argus Research

8 months ago

COLL: Lowering target price to $33.00

Collegium to Participate in Upcoming Investor Conferences

GlobeNewswire

8 months ago

Collegium to Participate in Upcoming Investor Conferences

Collegium Pharmaceutical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

8 months ago

Collegium Pharmaceutical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

GuruFocus.com

8 months ago

Collegium Pharmaceutical Inc (COLL) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...

Is the Options Market Predicting a Spike in Collegium Pharmaceutical (COLL) Stock?

Zacks

8 months ago

Is the Options Market Predicting a Spike in Collegium Pharmaceutical (COLL) Stock?

Here's What Key Metrics Tell Us About Collegium Pharmaceutical (COLL) Q3 Earnings

Zacks

8 months ago

Here's What Key Metrics Tell Us About Collegium Pharmaceutical (COLL) Q3 Earnings

Collegium Pharmaceutical (COLL) Q3 Earnings and Revenues Lag Estimates

Zacks

8 months ago

Collegium Pharmaceutical (COLL) Q3 Earnings and Revenues Lag Estimates

Associated Press Finance

8 months ago

Collegium Pharmaceutical: Q3 Earnings Snapshot

Collegium Reports Record Third Quarter 2024 Financial Results

GlobeNewswire

8 months ago

Collegium Reports Record Third Quarter 2024 Financial Results

Collegium Appoints Vikram Karnani as Chief Executive Officer

GlobeNewswire

8 months ago

Collegium Appoints Vikram Karnani as Chief Executive Officer

What To Expect From Collegium Pharmaceutical Inc (COLL) Q3 2024 Earnings

GuruFocus.com

8 months ago

What To Expect From Collegium Pharmaceutical Inc (COLL) Q3 2024 Earnings

Argus Research

8 months ago

COLL: Lowering target price to $35.00

Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks

8 months ago

Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Collegium Pharmaceutical to Report Q3 Earnings: What's in the Cards?

Zacks

8 months ago

Collegium Pharmaceutical to Report Q3 Earnings: What's in the Cards?

Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock?

Zacks

8 months ago

Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock?

Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024

GlobeNewswire

8 months ago

Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024

Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now?

Zacks

9 months ago

Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now?

GuruFocus.com

9 months ago

Collegium Pharmaceutical Inc (COLL) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Argus Research

9 months ago

COLL: Lowering target price to $40.00

Breakouts Boost These Three Stocks To All-Time Highs

Investor's Business Daily

9 months ago

Breakouts Boost These Three Stocks To All-Time Highs

Share on Social Networks: